NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said today that it will work with researchers at George Mason University to validate protein biomarkers GMU discovered using Thermo Fisher’s mass spectrometry technology.
 
Scientists at GMU’s Center for Applied Proteomics and Molecular Medicine (CAPMM) will use Thermo Fisher’s Quantum Ultra triple quadrupole mass spectrometers to discover cancer biomarkers, which the company will cross-validate at its Biomarker Research Initiatives in Mass Spectrometry Center.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.